SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany flag Germany · Delayed Price · Currency is EUR
23.10
0.00 (0.00%)
Feb 21, 2025, 9:00 AM CET

ETR:1SXP Income Statement

Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Revenue
954.68957.09898.6821.14648.67584.23
Revenue Growth (YoY)
5.42%6.51%9.43%26.59%11.03%-
Cost of Revenue
639.25634.48582.11524.51422.5388.22
Gross Profit
315.43322.61316.49296.64226.17196.01
Selling, General & Admin
126.19125.18122.68110.7892.589.63
Research & Development
25.0524.2526.8223.5322.2923.58
Other Operating Expenses
-16.29-15.67-4.23-5.68-3.12-8.18
Operating Expenses
134.95133.77145.28128.63111.67105.04
Operating Income
180.47188.84171.21168.01114.590.97
Interest Expense
-15.03-12.78-6.66-2.11-1.19-1.51
Interest & Investment Income
7.115.965.232.140.560.56
Earnings From Equity Investments
13.4812.4911.7412.9913.75.55
Currency Exchange Gain (Loss)
-22.49-11.092.71-7.03-1.450.45
Other Non Operating Income (Expenses)
-0.94-1.08-4.55-5.54-3.26-1.55
EBT Excluding Unusual Items
162.61182.35179.68168.46122.8794.46
Merger & Restructuring Charges
----11.78--
Gain (Loss) on Sale of Assets
0.590.590.391.510.30.72
Asset Writedown
--5.2---
Pretax Income
164.23183.97185.8158.29123.2895.3
Income Tax Expense
29.4233.6333.8732.4422.1217.67
Earnings From Continuing Operations
134.81150.35151.93125.85101.1777.63
Minority Interest in Earnings
-0.64-0.66-0.09-0.47-0.41-0.15
Net Income
134.17149.69151.84125.38100.7577.48
Net Income to Common
134.17149.69151.84125.38100.7577.48
Net Income Growth
-15.14%-1.42%21.11%24.44%30.04%-
Shares Outstanding (Basic)
150151151151151151
Shares Outstanding (Diluted)
150151151151151151
Shares Change (YoY)
-0.27%--0.00%--
EPS (Basic)
0.890.991.010.830.670.51
EPS (Diluted)
0.890.991.010.830.670.51
EPS Growth
-15.28%-1.80%21.46%24.08%31.17%-
Free Cash Flow
45.9980.256.1930.1134.1419.22
Free Cash Flow Per Share
0.310.530.040.200.230.13
Dividend Per Share
0.1600.1600.1500.125--
Dividend Growth
6.67%6.67%20.00%---
Gross Margin
33.04%33.71%35.22%36.13%34.87%33.55%
Operating Margin
18.90%19.73%19.05%20.46%17.65%15.57%
Profit Margin
14.05%15.64%16.90%15.27%15.53%13.26%
Free Cash Flow Margin
4.82%8.38%0.69%3.67%5.26%3.29%
EBITDA
244.53249217.5211.8150.94124.7
EBITDA Margin
25.61%26.02%24.20%25.79%23.27%21.34%
D&A For EBITDA
64.0660.1646.2943.7936.4433.73
EBIT
180.47188.84171.21168.01114.590.97
EBIT Margin
18.90%19.73%19.05%20.46%17.65%15.57%
Effective Tax Rate
17.91%18.28%18.23%20.49%17.94%18.54%
Source: S&P Capital IQ. Standard template. Financial Sources.